Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-19-001685)

Filing Details

Accession Number:: 0001225208-19-001685
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-01 19:21:46
Reporting Period:: 2019-01-30

Accepted Time:: 2019-02-01 19:21:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1488270	M Douglas Lankler	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-01-30	265	$41.21	83,592	No	4	S	Direct
Common Stock	Disposition	2019-01-30	900	$41.22	82,692	No	4	S	Direct
Common Stock	Disposition	2019-01-30	1,500	$41.17	81,192	No	4	S	Direct
Common Stock	Disposition	2019-01-30	1,800	$41.15	79,392	No	4	S	Direct
Common Stock	Disposition	2019-01-30	2,100	$41.16	77,292	No	4	S	Direct
Common Stock	Disposition	2019-01-30	6,000	$41.18	71,292	No	4	S	Direct
Common Stock	Disposition	2019-01-30	9,136	$41.20	62,156	No	4	S	Direct
Common Stock	Disposition	2019-01-30	17,099	$41.19	45,057	No	4	S	Direct
Common Stock	Disposition	2019-02-01	5,000	$42.75	40,057	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,503	Indirect	By Rule 16b-3 Plan